Natural history and complications of IBD

Current Gastroenterology Reports

Volumn 11, Issue 6, 2009, Pages 481-487

  Vatn, Morten H ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOSPORIN; GLUCOCORTICOID; INTERLEUKIN 10; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; ARTHRITIS; CANCER RISK; CHILD HEALTH; CLINICAL TRIAL; COLON; COLON RESECTION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; ERYTHEMA NODOSUM; GASTROINTESTINAL SURGERY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GEOGRAPHIC DISTRIBUTION; GROWTH RETARDATION; HEREDITY; HUMAN; ILEUM; IMMUNOMODULATION; INCIDENCE; INNATE IMMUNITY; MONOZYGOTIC TWINS; MUTATIONAL ANALYSIS; NUTRITIONAL DISORDER; ONSET AGE; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; POPULATION RESEARCH; PREGNANCY; PREVALENCE; PROCTITIS; PYODERMA GANGRENOSUM; RELAPSE; REOPERATION; REVIEW; RISK FACTOR; SACROILIITIS; SMOKING; TREATMENT RESPONSE; ULCERATIVE COLITIS; UVEITIS;

DISEASE PROGRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 72549109900     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0073-8     Document Type: Review

References (65)

1. M.D. Kappelman L. Sheryl C.Q. Porter, et al. 2008 Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults Gastroenterology 135 1907 1913 10.1053/j.gastro.2008.09.012 18854185
2. S. Odes H. Vardi M. Friger, et al. 2006 Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation Gastroenterology 131 719 728 10.1053/j.gastro. 2006.05.052 16952541 (Pubitemid 44307060)
3. J.E. Everhart C.E. Ruhl 2009 Burden of digestive diseases in the United States part II: lower gastrointestinal diseases Gastroenterology 136 741 754 10.1053/j.gastro.2009.01.015 19166855
4. A. Sonnenberg 2009 Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004 J Clin Gastroenterol 43 297 300 10.1097/MCG.0b013e31816244a0 18936713
5. T. Bernklev J. Jahnsen E. Aadland, et al. 2005 Course of disease, drug treatment and health related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis Eur J Gastroenterol Hepatol 17 1037 1045 10.1097/00042737-200510000-00006 16148548 (Pubitemid 41423996)
6. S. Shivananda J. Lennard-Jones R. Logan, et al. 1996 Incidence of inflammatory bowel disease across Europe. Is there a difference between north and south. Results of the European collaborative study on inflammatory bowel disease (EC-IBD) Gut 39 690 697 10.1136/gut.39.5.690 1:STN:280: DyaK2s7mslSkuw%3D%3D 9014768
7. F. Wolters M.G. Russel J. Sijbrandij, et al. 2006 Phenotype at diagnosis predicts recurrence rates in Crohn's disease Gut 55 1124 1130 10.1136/gut.2005.084061 1:STN:280:DC%2BD28vis1yrtA%3D%3D 16361306 (Pubitemid 44085679)
8. O. Hoie F. Wolters L. Riis, et al. 2007 Ulcerative colitis: patients characteristics may predict 10-years disease recurrence in a European-wide population-based cohort Am J Gastroenterol 102 1692 1701 10.1111/j.1572-0241. 2007.01265.x 17555460 (Pubitemid 47206689)
9. C.N. Bernstein A. Wajda L.W. Svenson, et al. 2006 The epidemiology of inflammatory bowel disease in Canada: a population-based study Am J Gastroenterol 101 1559 1568 10.1111/j.1572-0241.2006.00603.x 16863561 (Pubitemid 43980630)
10. C. Ott F. Obermaier S. Thieler, et al. 2008 The incidence of inflammatory bowel disease in a rural region of southern Germany: a prospective population-based study Eur J Gastroenterol Hepatol 20 917 923 10.1097/MEG.0b013e3282f97b33 18794607
11. G. Vernier-Massouille M. Balde J. Salleron, et al. 2008 Natural history of pediatric Crohn's disease: a population-based cohort study Gastroenterology 135 1106 1113 10.1053/j.gastro.2008.06.079 18692056
12. F. Guarner R. Bourdet-Sicard P. Brandtzaeg, et al. 2006 Mechanisms of disease: the hygiene hypothesis revisited Nat Clin Pract Gastroenterol Hepatol 3 275 284 10.1038/ncpgasthep0471 1:CAS:528:DC%2BD28Xlt1Kjtbo%3D 16673007 (Pubitemid 43675024)
13. R. Ley D. Peterson J. Gordon 2006 Ecological and evolutionary forces shaping microbial diversity in the human intestine Cell 124 837 848 10.1016/j.cell.2006.02.017 1:CAS:528:DC%2BD28Xit1Kltbs%3D 16497592 (Pubitemid 43261456)
14. H. Hildebrand 2004 On the generality of the latitudinal diversity gradient Am Nat 163 192 211 10.1086/381004 (Pubitemid 38335217)
15. C.E. Hayes F.E. Nashold M. Froicu, et al. 2003 The immunological functions of the vitamin D endocrine system Cell Mol Biol (Noisy-le-grand) 49 277 300 1:CAS:528:DC%2BD3sXls1KrtLw%3D
16. G. Aamodt G. Bukholm J. Jahnsen, et al. 2008 The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway Am J Gastroenterol 168 1065 1072
17. I.C. Solberg M.H. Vatn O. Hoie, et al. 2007 Clinical course in Crohn's disease: results of a population-based ten-year follow-up study Clin Gastroenterol Hepatol 5 1430 1438 10.1016/j.cgh.2007.09.002 18054751 (Pubitemid 350181602)
18. S.S. Mahid K.S. Minor R.E. Soto, et al. 2006 Smoking and inflammatory bowel disease: a meta-analysis Mayo Clin Proc 81 1462 1471 10.4065/81.11.1462 17120402
19. R.K. Russel R. Farhodi M. Wilson, et al. 2005 Perinatal passive smoke exposure may be more important than childhood exposure in the risk of developing childhood IBD Gut 54 1500 1501
20. F. van der Heide A. Dijkstra R.K. Weersma, et al. 2009 Effects of active and passive smoking on the disease course of Crohn's disease and ulcerative colitis Inflammatory Bowel Dis 15 1199 1207 10.1002/ibd.20884
21. M. Regueiro E.K. Kevin C. Onki, et al. 2005 Cigarette smoking and age at diagnosis of inflammatory bowel disease Inflamm Bowel Dis 11 42 47 10.1097/00054725-200501000-00006 15674112 (Pubitemid 40340255)
22. S. Bridger J.C.W. Lee I. Bjarnason, et al. 2002 Inflammatory bowel disease. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis Gut 51 21 25 10.1136/gut.51.1.21 1:STN:280: DC%2BD38zmtFKmsQ%3D%3D 12077086 (Pubitemid 34717738)
23. O. Hoie G. Aamodt S. Vermeire, et al. 2008 Serological markers may predict disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years J Crohn's Colitis (JCC) 2 114 122 10.1016/j.crohns.2007.10.001 (Pubitemid 351672116)
24. J. Halfvarson L. Bodin C. Tysk, et al. 2003 Inflammatory bowel disease in a Swedish cohort. A long-term follow up of concordance and clinical characteristics Gastroenterology 24 1767 1773 10.1016/S0016-5085(03)00385-8 (Pubitemid 36666773)
25. J. Satsangi L. Grootsholten H. Holt, et al. 1996 Clinical patterns of familial inflammatory bowel disease Gut 38 738 741 10.1136/gut.38.5.738 1:STN:280:DyaK28zjsV2ltA%3D%3D 8707121 (Pubitemid 26167483)
26. Bengtson M-B, Solberg IC, Aamodt G, et al.: Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease. Inflamm Bowel Dis 2009 (Epub ahead of print).
27. M. Slatkin 2009 Epigenetic inheritance and the missing heritability problem Genetics 182 845 850 10.1534/genetics.109.102798 19416939
28. M.T. Abreu K.D. Taylor Y.C. Lin, et al. 2002 Mutations in NOD2 are associated with fibrostenotic disease in patients with Crohn's disease Gastroenterology 123 679 688 10.1053/gast.2002.35393 1:CAS:528: DC%2BD38Xntl2mtbo%3D 12198692 (Pubitemid 34977073)
29. W. Strober I. Fuss P. Mannon 2007 The fundamental basis of inflammatory bowel disease J Clin Invest 117 514 521 10.1172/JCI30587 1:CAS:528: DC%2BD2sXis12hsbk%3D 17332878 (Pubitemid 46348505)
30. Franke A, Belchun T, Karlsen TH, et al.: Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2009, in press.
31. F.L. Wolters M.G. Russel J. Sijbrandij, et al. 2006 Crohn's disease: increased mortality 10 years after diagnosis in a European-wide population-based cohort Gut 55 510 518 10.1136/gut.2005.072793 1:STN:280:DC%2BD287kt1Crsw%3D%3D 16150857
32. O. Hoie L.J. Schouten F.L. Wolters 2007 Ulcerative colitis: no rise in mortality in a European-wide population-based cohort10 years after diagnosis Gut 56 497 503 10.1136/gut.2006.101519 1:STN:280:DC%2BD2s7msFahtA%3D%3D 17028127 (Pubitemid 46580504)
33. B. Moum A. Ekbom M.H. Vatn, et al. 1997 Clinical course during the first year after diagnosis in ulcerative colitis and Crohn's disease Scand J Gastroenterol 32 1005 1012 10.3109/00365529709011217 1:STN:280: DyaK1c%2FislSgtA%3D%3D 9361173
34. I.C. Solberg I. Lygren J. Jahnsen, et al. 2009 Clinical course during the first teten years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand J Gastroenterol 44 431 440 10.1080/00365520802600961 19101844
35. M. Henriksen J. Jahnsen I. Lygren, et al. 2006 Change of diagnosis during the first years after onset of inflammatory bowel disease: results of a prospective follow up study (the IBSEN study) Scand J Gastroenterol 41 1037 1043 10.1080/00365520600554527 16938716
36. E. Langholz P. Munkholm M. Davidsen, et al. 1994 Course of ulcerative colitis: analysis of change in disease activity over years Gastroenterology 107 3 11 1:STN:280:DyaK2c3ptFyltw%3D%3D 8020674
37. P. Munkholm E. Langholz M. Davidsen, et al. 1995 Disease activity courses in a regional cohort of Crohn's disease patients Scand J Gastroenterol 30 699 707 10.3109/00365529509096316 1:STN:280:DyaK28%2FmtlamsA%3D%3D 7481535
38. K. Geboes J.F. Colombel A. Greenstein, et al. 2008 Indeterminate colitis: a review of the concept-what is in a name? Inflamm Bowel Dis 14 850 857 10.1002/ibd.20361 18213696 (Pubitemid 351898070)
39. O. Hoie F.L. Wolters L. Riis, et al. 2007 Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years Gastroenterology 132 507 515 10.1053/j.gastro.2006.11.015 17258717 (Pubitemid 46298736)
40. L. Beaugerie P. Seksik I. Nion-Larmurier 2006 Predictors of Crohn's disease Gastroenterology 130 650 656 10.1053/j.gastro.2005.12.019 16530505 (Pubitemid 43374514)
41. C. Loly J. Belaiche E. Louis 2008 Predictors of severe Crohn's disease Scand J Gastroenterol 43 948 954 10.1080/00365520801957149 1:CAS:528: DC%2BD1cXovFWkt7s%3D 19086165
42. G. Latella A. Cocco A. Angeluchi, et al. 2009 Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen Dig Liver Dis 41 269 276 10.1016/j.dld.2008.09.010 1:STN:280:DC%2BD1M3hvFChsA%3D%3D 18955023
43. M. Lemann J.-Y. Mary J.F.A. Colombel 2005 A randomized double blind controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine Gastroenterology 128 1812 1818 10.1053/j.gastro.2005.03.031 1:CAS:528:DC%2BD2MXlvFKls7k%3D 15940616 (Pubitemid 40824692)
44. S. Renna C. Camma I. Modesto, et al. 2008 Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease Gastroenterology 135 1500 1509 10.1053/j.gastro.2008.07.066 1:CAS:528:DC%2BD1cXhsVOhtb3E 18823987
45. J. Cosnes F. Carbonell L. Beaugerie, et al. 2002 Effects of appendicectomy on the course of ulcerative colitis Gut 51 803 807 10.1136/gut.51.6.803 1:STN:280:DC%2BD38nmslehsg%3D%3D 12427780 (Pubitemid 35408599)
46. J. van Limbergen R.K. Russel H.E. Drummond, et al. 2008 Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease Gastroenterology 135 1114 1122 10.1053/j.gastro.2008.06.081 18725221
47. G. Perminow D.H. Reikvam L.G. Lyckander, et al. 2009 Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease Inflamm Bowel Dis 15 1368 1378 10.1002/ibd.20916 19322902
48. U. Mahadevan W.J. Sandborn D.K. Li, et al. 2007 Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California Gastroenterology 133 1106 12 10.1053/j.gastro.2007.07.019 17764676 (Pubitemid 47494456)
49. D. Reddy S.J. Murphy S.V. Kane 2008 Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes Am J Gastroenterol 103 1203 1209 10.1111/j.1572-0241.2007.01756.x 1:CAS:528:DC%2BD1cXntFCrsrg%3D 18422816 (Pubitemid 351677969)
50. Mahadevan-Velayos U, Martin C, Sandler R, et al.: PIANO. Pregnancy in inflammatory bowel disease and neonatal outcomes: a national prospective registry. Presented at Digestive Disease Week. Chicago; May 30-June 4, 2009.
51. C.N. Bernstein J.F. Blanchard E. Kliewer 2001 Cancer risk in patients with inflammatory bowel disease. A populationbased study Cancer 91 854 862 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z 1:STN:280:DC%2BD3M3hsFWluw%3D%3D 11241255 (Pubitemid 32173312)
52. S. Brackmann S.N. Andersen G. Aamodt, et al. 2009 Two distinct groups of colorectal cancer in inflammatory bowel disease Inflamm Bowel Dis 15 9 16 10.1002/ibd.20542 18618636
53. Y. Masunuga K. Ohuo R. Ogawa 2007 Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease Ann Pharmacother 41 21 28
54. S.B. Hanauer B.G. Feagan G.R. Lichtenstein, et al. 2002 Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial Lancet 359 1541 1549 10.1016/S0140-6736(02)08512-4 1:CAS:528:DC%2BD38Xkt1Gru70%3D 12047962 (Pubitemid 34621118)
55. B. Sands F.H. Anderson C.N. Bernstein, et al. 2004 Infliximab maintenance therapy for fistulizing Crohn's disease N Engl J Med 350 876 985 10.1056/NEJMoa030815 1:CAS:528:DC%2BD2cXhsFyitLo%3D 14985485 (Pubitemid 38252535)
56. Kamm MA, Hanauer SB, Pannachione R, et al.: Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM. Poster presented at 4th Congress of the European Crohn's and Colitis Organization. Hamburg, Germany; February 5-7, 2009.
57. P. Rutgeerts W.J. Sandborn B.G. Feagan, et al. 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 2476 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE 16339095 (Pubitemid 41770166)
58. G. Jarnerot E. Hertervig I. Friis-Liby, et al. 2005 Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized placebo-controlled study Gastroenterology 128 1805 1811 10.1053/j.gastro.2005. 03.003 15940615 (Pubitemid 40824691)
59. S. Dhillon E.V. Loftus W.J. Tremaine, et al. 2005 The natural history of surgery for ulcerative colitis in a population-based cohort from Olmsted County, Minnesota [abstract 819] Am J Gastroenterol 100 S303
60. C.N. Bernstein J.F. Blanchard P. Rawsthorne, et al. 2001 The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study Am J Gastroenterol 96 116 122
61. T.R. Orchard H. Holt L. Bradbury, et al. 2009 The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease Aliment Pharmacol Ther 29 193 197 10.1111/j.1365-2036.2008. 03868.x 1:STN:280:DC%2BD1M%2Fls1KrsQ%3D%3D 18945256
62. I. Yuksel O. Basar H. Ataseven, et al. 2009 Mucocutaneous manifestations in inflammatory bowel disease Inflamm Bowel Dis 15 546 550 10.1002/ibd.20807 19023896
63. F.A. Jose E.A. Garnett E. Vittinghoff, et al. 2009 Development of extraintestinal manifestations inpediatric patients with inflammatory bowel disease Inflamm Bowel Dis 15 63 68 10.1002/ibd.20604 18626963
64. F.A. Jose M.B. Heyman 2008 Extraintestinal manifestations of inflammatory bowel disease J Pediatr Gastroenterol Nutr 46 124 133 10.1097/MPG. 0b013e318093f4b0 18223370 (Pubitemid 351161117)
65. A. Papa F. Scaldaferri S. Danses, et al. 2008 Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects Dig Dis 26 149 155 10.1159/000116773 18431065 (Pubitemid 351572140)